Spyre Therapeutics, Inc. (SYRE)
35.12
+2.18
(+6.62%)
USD |
NASDAQ |
Feb 06, 16:00
35.13
+0.01
(+0.03%)
After-Hours: 20:00
Spyre Therapeutics Research and Development Expense (TTM) : 177.50M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| PTC Therapeutics, Inc. | 446.89M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Savara, Inc. | 83.80M |
| BioMarin Pharmaceutical, Inc. | 682.06M |